FNDC5 and psoriasis: Comparing median irisin levels in each of the three groups (stratified on the basis of PASI scores) with levels in control subjects, we found that irisin was higher in patients with mild psoriasis compared to controls and to patients with more severe psoriasis (Figure 3).